saxagliptin for the treatment of type 2 diabetes mellitus focus on recent studies

Analysis metformin as firstline treatment for type 2 diabetes: are we sure? bmj 2016; 352 doi: https://doi.org/10.1136/bmj.h6748 (published 08 january 2016) cite this.

Management of hyperglycemia in patients with type 2 diabetes and pre-dialysis chronic kidney disease or end-stage renal disease. Analysis metformin as firstline treatment for type 2 diabetes: are we sure? bmj 2016; 352 doi: https://doi.org/10.1136/bmj.h6748 (published 08 january 2016) cite this. Original article. effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. jennifer b. green, m.d., m. angelyn bethel, m.d., paul w. armstrong, m.d., john.

Original article. effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. jennifer b. green, m.d., m. angelyn bethel, m.d., paul w. armstrong, m.d., john.

The prevalence of type 2 diabetes continues to increase steadily as more people live longer and grow heavier. from 1995 to 2004, the overall prevalence of type 2. Type 2 diabetes mellitus, the sixth leading cause of death in the united states, is directly responsible for more than 73,000 deaths annually and is a contributing. All people with type 2 diabetes have insulin resistance. insulin resistance exists in a person years before the diabetes is diagnosed, and the presence of insulin.